Found: 74
Select item for more details and to access through your institution.
Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1254, doi. 10.1002/ajh.26991
- By:
- Publication type:
- Article
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 140, doi. 10.1002/ajh.26596
- By:
- Publication type:
- Article
Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agents.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 792, doi. 10.1002/ajh.25808
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 879, doi. 10.1002/ajh.24792
- By:
- Publication type:
- Article
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 883, doi. 10.1002/ajh.24424
- By:
- Publication type:
- Article
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 672, doi. 10.1002/ajh.24372
- By:
- Publication type:
- Article
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 426, doi. 10.1002/ajh.24308
- By:
- Publication type:
- Article
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 453, doi. 10.1002/ajh.24303
- By:
- Publication type:
- Article
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 426, doi. 10.1002/ajh.24308
- By:
- Publication type:
- Article
Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 12, p. 1017, doi. 10.1002/ajh.23561
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 10, p. 890, doi. 10.1002/ajh.23524
- By:
- Publication type:
- Article
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 8, p. 657, doi. 10.1002/ajh.23468
- By:
- Publication type:
- Article
Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 11, p. 846, doi. 10.1002/ajh.21268
- By:
- Publication type:
- Article
Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 9, p. 747, doi. 10.1002/ajh.21236
- By:
- Publication type:
- Article
Post-transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 12, p. 1071, doi. 10.1002/ajh.21038
- By:
- Publication type:
- Article
Recommended Guidelines for the Management of Autologous and Alogeneic Bone Marrow Transplantation.
- Published in:
- Annals of Internal Medicine, 1994, v. 120, n. 2, p. 143, doi. 10.7326/0003-4819-120-2-199401150-00008
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 322, doi. 10.1111/ejh.13909
- By:
- Publication type:
- Article
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 2003, doi. 10.1093/cid/ciy822
- By:
- Publication type:
- Article
Bortezomib in Relapsed or Refractory Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 74
- By:
- Publication type:
- Article
Bortezomib-Induced Tumor Lysis Syndrome in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 3, p. 233
- By:
- Publication type:
- Article
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 3, p. 303, doi. 10.1007/s40487-023-00232-9
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.
- Published in:
- Current Oncology Reports, 2002, v. 4, n. 5, p. 375, doi. 10.1007/s11912-002-0030-2
- By:
- Publication type:
- Article
Radioimmunotherapy of Non-Hodgkin's Lymphoma with <sup>90</sup>Y-DOTA Humanized Anti-CD22 IgG (<sup>90</sup>Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 12, p. 2000
- By:
- Publication type:
- Article
Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
- Published in:
- 2009
- By:
- Publication type:
- letter
Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis.
- Published in:
- 2009
- By:
- Publication type:
- Letter
OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
- By:
- Publication type:
- Article
Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e124, doi. 10.1016/j.clml.2019.09.206
- By:
- Publication type:
- Article
Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
- By:
- Publication type:
- Article
Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment Crossover in the CALGB/ECOG 100104 (Alliance) Study of Lenalidomide (LEN) Versus Placebo (PBO) Maintenance After Stem Cell Transplant (SCT) for Patients With Newly Diagnosed Multiple Myeloma
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e135, doi. 10.1016/j.clml.2017.03.244
- By:
- Publication type:
- Article
Melphalan/Total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The evolving role of plerixafor in hematopoietic progenitor cell mobilization.
- Published in:
- Transfusion, 2013, v. 53, n. 10, p. 2314, doi. 10.1111/trf.12102
- By:
- Publication type:
- Article
A phase 1 study of lucatumumab, a fully human anti- CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 1, p. 58, doi. 10.1111/j.1365-2141.2012.09251.x
- By:
- Publication type:
- Article
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 4, p. 531, doi. 10.1111/j.1365-2141.2009.07875.x
- By:
- Publication type:
- Article
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 2, p. 164, doi. 10.1111/j.1365-2141.2009.07728.x
- By:
- Publication type:
- Article
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 6, p. 895, doi. 10.1111/j.1365-2141.2008.07573.x
- By:
- Publication type:
- Article
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 1, p. 46, doi. 10.1111/j.1365-2141.2008.07303.x
- By:
- Publication type:
- Article
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 5, p. 429, doi. 10.1111/j.1365-2141.2007.06585.x
- By:
- Publication type:
- Article
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 2, p. 174, doi. 10.1111/j.1365-2141.2006.06280.x
- By:
- Publication type:
- Article
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 426, doi. 10.1111/j.1600-0609.2009.01257.x
- By:
- Publication type:
- Article
High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic Transplantation.
- Published in:
- Clinical Infectious Diseases, 2003, v. 36, n. 1, p. 9, doi. 10.1086/344906
- By:
- Publication type:
- Article
Infectious Complications the Year after Autologous Bone Marrow Transplantation of Peripheral...
- Published in:
- Clinical Infectious Diseases, 2001, v. 32, n. 3, p. 391, doi. 10.1086/318491
- By:
- Publication type:
- Article
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 9, p. 1837, doi. 10.1002/cncr.32659
- By:
- Publication type:
- Article
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1429, doi. 10.1111/bjh.19326
- By:
- Publication type:
- Article
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 3, p. 326, doi. 10.1111/bjh.18108
- By:
- Publication type:
- Article